Showing results (411-420 of 425) with videos related to

Sort By:
Pageof 43
Therapeutic Advances in Medical Oncology|August 7, 2023
PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimensHui Chen, Qingqing Ding, Laila Khazai, et al.
Breast Cancer Research : BCR|May 7, 2026
The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancerSahil Seth, Clinton Yam, Lei Huo, et al.
Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancerJorge Gomez Tejeda Zanudo, Busem Binboga Kurt, Allison Frangieh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast CancerClinton Yam, Er-Yen Yen, Jeffrey T Chang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 30, 2026
A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance StudyTia L Kauffman, Elizabeth K O'Donnell, Catherine R Marinac, et al.
JNCI Cancer Spectrum|May 25, 2026
Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohortStefania Morganti, Se E Kim, Qingchun Jin, et al.
Cancers|September 10, 2021
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx® Digital Spatial ProfilerHelga Bergholtz, Jodi M Carter, Alessandra Cesano, et al.
Cancer Research|July 14, 2023
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast CancerFrancisco Hermida-Prado, Yingtian Xie, Shira Sherman, et al.
Annals of Surgical Oncology|June 25, 2024
The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT StudyChirag Shah, Pat Whitworth, Frank A Vicini, et al.
Cancer Research Communications|October 2, 2024
Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II StudyClinton Yam, Miral Patel, Holly A Hill, et al.
Pageof 43